Intuitive Surgical, Inc. (NASDAQ: ISRG) Stock Competitors & Peer Comparison
See ISRG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ISRG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ISRG | $345.42 | -11.20% | 142.5B | 41.82 | $9.62 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.68 | +1.87% | 175.3B | 19.32 | $5.21 | +2.48% |
| SYK | $319.87 | -3.42% | 122.6B | 23.89 | $13.39 | +1.09% |
| MDT | $83.20 | -0.43% | 106.5B | 15.04 | $5.53 | +3.43% |
| BSX | $44.03 | -1.32% | 65.4B | 14.20 | $3.10 | N/A |
| EW | $85.73 | -2.40% | 49.4B | 31.75 | $2.70 | N/A |
| DXCM | $76.65 | -1.71% | 29.6B | 32.90 | $2.33 | N/A |
| RMD | $198.99 | -1.86% | 28.9B | 18.47 | $10.77 | +1.21% |
| ZBH | $91.12 | -2.81% | 17.6B | 10.75 | $8.48 | +1.05% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
ISRG vs BSX-PA Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, ISRG's ROE is +0.17%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, ISRG is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
ISRG vs ABT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ABT has a market cap of 175.3B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ABT trades at $100.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ABT's P/E ratio is 19.32. In terms of profitability, ISRG's ROE is +0.17%, compared to ABT's ROE of +0.12%. Regarding short-term risk, ISRG is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ABT's competition here
Stryker Corporation (NYSE: SYK)
ISRG vs SYK Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SYK has a market cap of 122.6B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SYK trades at $319.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SYK's P/E ratio is 23.89. In terms of profitability, ISRG's ROE is +0.17%, compared to SYK's ROE of +0.15%. Regarding short-term risk, ISRG is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SYK's competition here
Medtronic plc (NYSE: MDT)
ISRG vs MDT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, MDT has a market cap of 106.5B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while MDT trades at $83.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas MDT's P/E ratio is 15.04. In terms of profitability, ISRG's ROE is +0.17%, compared to MDT's ROE of +0.10%. Regarding short-term risk, ISRG is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
ISRG vs BSX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BSX has a market cap of 65.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BSX trades at $44.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BSX's P/E ratio is 14.20. In terms of profitability, ISRG's ROE is +0.17%, compared to BSX's ROE of +0.15%. Regarding short-term risk, ISRG is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
ISRG vs EW Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, EW has a market cap of 49.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while EW trades at $85.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas EW's P/E ratio is 31.75. In terms of profitability, ISRG's ROE is +0.17%, compared to EW's ROE of +0.11%. Regarding short-term risk, ISRG is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
ISRG vs DXCM Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, DXCM has a market cap of 29.6B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while DXCM trades at $76.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas DXCM's P/E ratio is 32.90. In terms of profitability, ISRG's ROE is +0.17%, compared to DXCM's ROE of +0.34%. Regarding short-term risk, ISRG is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
ISRG vs RMD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, RMD has a market cap of 28.9B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while RMD trades at $198.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas RMD's P/E ratio is 18.47. In terms of profitability, ISRG's ROE is +0.17%, compared to RMD's ROE of +0.24%. Regarding short-term risk, ISRG is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check RMD's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
ISRG vs ZBH Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ZBH trades at $91.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ZBH's P/E ratio is 10.75. In terms of profitability, ISRG's ROE is +0.17%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, ISRG is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
ISRG vs ABMD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ABMD's P/E ratio is 65.36. In terms of profitability, ISRG's ROE is +0.17%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, ISRG is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ABMD's competition here
Smith & Nephew plc (NYSE: SNN)
ISRG vs SNN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SNN has a market cap of 12.9B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SNN trades at $30.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SNN's P/E ratio is 16.53. In terms of profitability, ISRG's ROE is +0.17%, compared to SNN's ROE of +0.12%. Regarding short-term risk, ISRG is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
ISRG vs ALGN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ALGN has a market cap of 12.7B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ALGN trades at $176.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ALGN's P/E ratio is 16.11. In terms of profitability, ISRG's ROE is +0.17%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, ISRG is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ALGN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
ISRG vs SWAV Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SWAV's P/E ratio is 78.76. In terms of profitability, ISRG's ROE is +0.17%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, ISRG is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
ISRG vs PEN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while PEN trades at $318.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas PEN's P/E ratio is 83.11. In terms of profitability, ISRG's ROE is +0.17%, compared to PEN's ROE of +0.12%. Regarding short-term risk, ISRG is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check PEN's competition here
Insulet Corp. (NASDAQ: PODD)
ISRG vs PODD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, PODD has a market cap of 11.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while PODD trades at $164.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas PODD's P/E ratio is 30.49. In terms of profitability, ISRG's ROE is +0.17%, compared to PODD's ROE of +0.21%. Regarding short-term risk, ISRG is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check PODD's competition here
Globus Medical, Inc. (NYSE: GMED)
ISRG vs GMED Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, GMED has a market cap of 10.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while GMED trades at $77.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas GMED's P/E ratio is 17.34. In terms of profitability, ISRG's ROE is +0.17%, compared to GMED's ROE of +0.13%. Regarding short-term risk, ISRG is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
ISRG vs MASI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas MASI's P/E ratio is 44.43. In terms of profitability, ISRG's ROE is +0.17%, compared to MASI's ROE of +0.09%. Regarding short-term risk, ISRG is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
ISRG vs GKOS Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, GKOS has a market cap of 9.2B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while GKOS trades at $156.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas GKOS's P/E ratio is -182.44. In terms of profitability, ISRG's ROE is +0.17%, compared to GKOS's ROE of -0.26%. Regarding short-term risk, ISRG is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check GKOS's competition here
Bruker Corporation (NASDAQ: BRKR)
ISRG vs BRKR Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BRKR has a market cap of 8.9B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BRKR trades at $58.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BRKR's P/E ratio is 31.99. In terms of profitability, ISRG's ROE is +0.17%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, ISRG is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BRKR's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
ISRG vs BIO-B Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BIO-B has a market cap of 8.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BIO-B trades at $324.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BIO-B's P/E ratio is 96.41. In terms of profitability, ISRG's ROE is +0.17%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, ISRG is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
ISRG vs BIO Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BIO has a market cap of 8.2B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BIO trades at $304.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BIO's P/E ratio is 32.81. In terms of profitability, ISRG's ROE is +0.17%, compared to BIO's ROE of +0.02%. Regarding short-term risk, ISRG is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BIO's competition here
Inari Medical, Inc. (NASDAQ: NARI)
ISRG vs NARI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas NARI's P/E ratio is -59.24. In terms of profitability, ISRG's ROE is +0.17%, compared to NARI's ROE of -0.00%. Regarding short-term risk, ISRG is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
ISRG vs LIVN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while LIVN trades at $80.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas LIVN's P/E ratio is 20.18. In terms of profitability, ISRG's ROE is +0.17%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, ISRG is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
ISRG vs IRTC Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while IRTC trades at $110.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas IRTC's P/E ratio is -205.98. In terms of profitability, ISRG's ROE is +0.17%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, ISRG is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
ISRG vs AXNX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas AXNX's P/E ratio is -709.80. In terms of profitability, ISRG's ROE is +0.17%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, ISRG is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AXNX's competition here
Integer Holdings Corporation (NYSE: ITGR)
ISRG vs ITGR Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ITGR has a market cap of 3.4B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ITGR trades at $95.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ITGR's P/E ratio is 15.81. In terms of profitability, ISRG's ROE is +0.17%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, ISRG is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ITGR's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
ISRG vs ESTA Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ESTA has a market cap of 2.7B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ESTA trades at $92.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ESTA's P/E ratio is -64.29. In terms of profitability, ISRG's ROE is +0.17%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, ISRG is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ESTA's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
ISRG vs TMDX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, TMDX has a market cap of 2.6B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while TMDX trades at $73.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas TMDX's P/E ratio is 30.20. In terms of profitability, ISRG's ROE is +0.17%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, ISRG is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
ISRG vs AXGN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, AXGN has a market cap of 2.1B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while AXGN trades at $39.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas AXGN's P/E ratio is 104.87. In terms of profitability, ISRG's ROE is +0.17%, compared to AXGN's ROE of -0.21%. Regarding short-term risk, ISRG is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AXGN's competition here
NuVasive, Inc. (NASDAQ: NUVA)
ISRG vs NUVA Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas NUVA's P/E ratio is 75.00. In terms of profitability, ISRG's ROE is +0.17%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, ISRG is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check NUVA's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
ISRG vs UFPT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while UFPT trades at $242.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas UFPT's P/E ratio is 25.21. In terms of profitability, ISRG's ROE is +0.17%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, ISRG is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check UFPT's competition here
Novocure Ltd (NASDAQ: NVCR)
ISRG vs NVCR Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while NVCR trades at $15.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas NVCR's P/E ratio is -10.41. In terms of profitability, ISRG's ROE is +0.17%, compared to NVCR's ROE of -0.51%. Regarding short-term risk, ISRG is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check NVCR's competition here
Butterfly Network, Inc. (NYSE: BFLY)
ISRG vs BFLY Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BFLY trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BFLY's P/E ratio is -27.54. In terms of profitability, ISRG's ROE is +0.17%, compared to BFLY's ROE of -0.37%. Regarding short-term risk, ISRG is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
ISRG vs ENOV Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ENOV trades at $27.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ENOV's P/E ratio is 8.01. In terms of profitability, ISRG's ROE is +0.17%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, ISRG is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
ISRG vs IART Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, IART has a market cap of 1.5B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while IART trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas IART's P/E ratio is 8.41. In terms of profitability, ISRG's ROE is +0.17%, compared to IART's ROE of -0.48%. Regarding short-term risk, ISRG is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IART's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
ISRG vs AHCO Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, AHCO has a market cap of 1.5B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while AHCO trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas AHCO's P/E ratio is 24.91. In terms of profitability, ISRG's ROE is +0.17%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, ISRG is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AHCO's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
ISRG vs INSP Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, INSP has a market cap of 1.5B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while INSP trades at $50.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas INSP's P/E ratio is 19.97. In terms of profitability, ISRG's ROE is +0.17%, compared to INSP's ROE of +0.18%. Regarding short-term risk, ISRG is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check INSP's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
ISRG vs ATEC Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ATEC has a market cap of 1.3B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ATEC trades at $8.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ATEC's P/E ratio is -77.59. In terms of profitability, ISRG's ROE is +0.17%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, ISRG is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ATEC's competition here
Heska Corporation (NASDAQ: HSKA)
ISRG vs HSKA Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas HSKA's P/E ratio is -62.49. In terms of profitability, ISRG's ROE is +0.17%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, ISRG is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HSKA's competition here
CONMED Corporation (NYSE: CNMD)
ISRG vs CNMD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CNMD has a market cap of 1.3B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CNMD trades at $43.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CNMD's P/E ratio is 9.51. In terms of profitability, ISRG's ROE is +0.17%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, ISRG is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CNMD's competition here
IRadimed Corporation (NASDAQ: IRMD)
ISRG vs IRMD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while IRMD trades at $97.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas IRMD's P/E ratio is 49.13. In terms of profitability, ISRG's ROE is +0.17%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, ISRG is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check IRMD's competition here
Artivion, Inc. (NYSE: AORT)
ISRG vs AORT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while AORT trades at $25.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas AORT's P/E ratio is 38.51. In terms of profitability, ISRG's ROE is +0.17%, compared to AORT's ROE of +0.03%. Regarding short-term risk, ISRG is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AORT's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
ISRG vs TNDM Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while TNDM trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas TNDM's P/E ratio is -15.53. In terms of profitability, ISRG's ROE is +0.17%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, ISRG is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check TNDM's competition here
Avanos Medical, Inc. (NYSE: AVNS)
ISRG vs AVNS Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while AVNS trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas AVNS's P/E ratio is 27.76. In terms of profitability, ISRG's ROE is +0.17%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, ISRG is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
ISRG vs SILK Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SILK's P/E ratio is -18.96. In terms of profitability, ISRG's ROE is +0.17%, compared to SILK's ROE of -0.35%. Regarding short-term risk, ISRG is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
ISRG vs FNA Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas FNA's P/E ratio is -19.83. In terms of profitability, ISRG's ROE is +0.17%, compared to FNA's ROE of -0.35%. Regarding short-term risk, ISRG is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check FNA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
ISRG vs PRCT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while PRCT trades at $19.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas PRCT's P/E ratio is -10.56. In terms of profitability, ISRG's ROE is +0.17%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, ISRG is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
ISRG vs LMRI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while LMRI trades at $11.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas LMRI's P/E ratio is -21.67. In terms of profitability, ISRG's ROE is +0.17%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, ISRG is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check LMRI's competition here
InMode Ltd. (NASDAQ: INMD)
ISRG vs INMD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, INMD has a market cap of 896.4M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while INMD trades at $15.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas INMD's P/E ratio is 10.00. In terms of profitability, ISRG's ROE is +0.17%, compared to INMD's ROE of +0.13%. Regarding short-term risk, ISRG is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
ISRG vs CSII Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CSII's P/E ratio is -20.83. In terms of profitability, ISRG's ROE is +0.17%, compared to CSII's ROE of -0.14%. Regarding short-term risk, ISRG is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CSII's competition here
Bioventus Inc. (NASDAQ: BVS)
ISRG vs BVS Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BVS has a market cap of 817M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BVS trades at $12.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BVS's P/E ratio is 16.08. In terms of profitability, ISRG's ROE is +0.17%, compared to BVS's ROE of +0.16%. Regarding short-term risk, ISRG is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check BVS's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
ISRG vs SIBN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SIBN has a market cap of 770.8M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SIBN trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SIBN's P/E ratio is -44.56. In terms of profitability, ISRG's ROE is +0.17%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, ISRG is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SIBN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
ISRG vs SSII Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SSII has a market cap of 742.5M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SSII trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SSII's P/E ratio is -72.36. In terms of profitability, ISRG's ROE is +0.17%, compared to SSII's ROE of -0.23%. Regarding short-term risk, ISRG is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SSII's competition here
CeriBell, Inc. (NASDAQ: CBLL)
ISRG vs CBLL Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CBLL has a market cap of 710.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CBLL trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CBLL's P/E ratio is -11.48. In terms of profitability, ISRG's ROE is +0.17%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, ISRG is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
ISRG vs TCMD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, TCMD has a market cap of 648.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while TCMD trades at $28.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas TCMD's P/E ratio is 32.66. In terms of profitability, ISRG's ROE is +0.17%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, ISRG is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
ISRG vs CERS Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CERS has a market cap of 627.2M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CERS trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CERS's P/E ratio is -62.48. In terms of profitability, ISRG's ROE is +0.17%, compared to CERS's ROE of -0.15%. Regarding short-term risk, ISRG is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CERS's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
ISRG vs BWAY Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BWAY has a market cap of 617M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BWAY trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BWAY's P/E ratio is 39.96. In terms of profitability, ISRG's ROE is +0.17%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, ISRG is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check BWAY's competition here
Surmodics, Inc. (NASDAQ: SRDX)
ISRG vs SRDX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SRDX's P/E ratio is -34.66. In terms of profitability, ISRG's ROE is +0.17%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, ISRG is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
ISRG vs CTKB Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CTKB has a market cap of 596.6M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CTKB trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CTKB's P/E ratio is -35.54. In terms of profitability, ISRG's ROE is +0.17%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, ISRG is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CTKB's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
ISRG vs APEN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas APEN's P/E ratio is -9.43. In terms of profitability, ISRG's ROE is +0.17%, compared to APEN's ROE of -0.85%. Regarding short-term risk, ISRG is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check APEN's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
ISRG vs NPCE Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, NPCE has a market cap of 548.2M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while NPCE trades at $16.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas NPCE's P/E ratio is -27.72. In terms of profitability, ISRG's ROE is +0.17%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, ISRG is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check NPCE's competition here
ZimVie Inc. (NASDAQ: ZIMV)
ISRG vs ZIMV Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, ISRG's ROE is +0.17%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, ISRG is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ZIMV's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
ISRG vs KIDS Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, KIDS has a market cap of 493.5M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while KIDS trades at $19.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas KIDS's P/E ratio is -18.66. In terms of profitability, ISRG's ROE is +0.17%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, ISRG is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check KIDS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
ISRG vs OFIX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, OFIX has a market cap of 468.1M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while OFIX trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas OFIX's P/E ratio is -47.17. In terms of profitability, ISRG's ROE is +0.17%, compared to OFIX's ROE of -0.13%. Regarding short-term risk, ISRG is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
ISRG vs CLPT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CLPT has a market cap of 454.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CLPT trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CLPT's P/E ratio is -15.00. In terms of profitability, ISRG's ROE is +0.17%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, ISRG is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CLPT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
ISRG vs PACB Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, PACB has a market cap of 447.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while PACB trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas PACB's P/E ratio is -2.94. In terms of profitability, ISRG's ROE is +0.17%, compared to PACB's ROE of -4.88%. Regarding short-term risk, ISRG is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check PACB's competition here
Varex Imaging Corporation (NASDAQ: VREX)
ISRG vs VREX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, VREX has a market cap of 444.2M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while VREX trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas VREX's P/E ratio is 11.11. In terms of profitability, ISRG's ROE is +0.17%, compared to VREX's ROE of -0.18%. Regarding short-term risk, ISRG is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check VREX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
ISRG vs DCTH Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, DCTH has a market cap of 442.2M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while DCTH trades at $12.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas DCTH's P/E ratio is 1281.00. In terms of profitability, ISRG's ROE is +0.17%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, ISRG is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check DCTH's competition here
Electromed, Inc. (AMEX: ELMD)
ISRG vs ELMD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ELMD has a market cap of 348.8M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ELMD trades at $42.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ELMD's P/E ratio is 36.00. In terms of profitability, ISRG's ROE is +0.17%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, ISRG is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ELMD's competition here
Carlsmed, Inc. (NASDAQ: CARL)
ISRG vs CARL Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CARL has a market cap of 317M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CARL trades at $11.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CARL's P/E ratio is -4.65. In terms of profitability, ISRG's ROE is +0.17%, compared to CARL's ROE of -0.62%. Regarding short-term risk, ISRG is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CARL's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
ISRG vs AVR Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, AVR has a market cap of 310.9M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while AVR trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas AVR's P/E ratio is -3.79. In terms of profitability, ISRG's ROE is +0.17%, compared to AVR's ROE of -1.24%. Regarding short-term risk, ISRG is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check AVR's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
ISRG vs SMLR Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SMLR's P/E ratio is 3.92. In terms of profitability, ISRG's ROE is +0.17%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, ISRG is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
ISRG vs TMCI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, TMCI has a market cap of 279M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while TMCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas TMCI's P/E ratio is -4.57. In terms of profitability, ISRG's ROE is +0.17%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, ISRG is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check TMCI's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
ISRG vs SGHT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SGHT has a market cap of 273.7M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SGHT trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SGHT's P/E ratio is -7.08. In terms of profitability, ISRG's ROE is +0.17%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, ISRG is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SGHT's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
ISRG vs MGRM Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas MGRM's P/E ratio is -12.00. In terms of profitability, ISRG's ROE is +0.17%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, ISRG is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check MGRM's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
ISRG vs CATX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CATX has a market cap of 230.7M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CATX trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CATX's P/E ratio is -2.12. In terms of profitability, ISRG's ROE is +0.17%, compared to CATX's ROE of -0.42%. Regarding short-term risk, ISRG is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check CATX's competition here
RxSight, Inc. (NASDAQ: RXST)
ISRG vs RXST Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, RXST has a market cap of 229.8M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while RXST trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas RXST's P/E ratio is -7.71. In terms of profitability, ISRG's ROE is +0.17%, compared to RXST's ROE of -0.17%. Regarding short-term risk, ISRG is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check RXST's competition here
Nevro Corp. (NYSE: NVRO)
ISRG vs NVRO Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas NVRO's P/E ratio is -1.91. In terms of profitability, ISRG's ROE is +0.17%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, ISRG is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check NVRO's competition here
Picard Medical, Inc. (AMEX: PMI)
ISRG vs PMI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, PMI has a market cap of 220.4M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while PMI trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas PMI's P/E ratio is -0.12. In terms of profitability, ISRG's ROE is +0.17%, compared to PMI's ROE of +4.99%. Regarding short-term risk, ISRG is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check PMI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
ISRG vs SENS Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, SENS has a market cap of 213.6M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while SENS trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas SENS's P/E ratio is -2.56. In terms of profitability, ISRG's ROE is +0.17%, compared to SENS's ROE of -1.30%. Regarding short-term risk, ISRG is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check SENS's competition here
Profound Medical Corp. (NASDAQ: PROF)
ISRG vs PROF Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, PROF has a market cap of 207.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while PROF trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas PROF's P/E ratio is -5.52. In terms of profitability, ISRG's ROE is +0.17%, compared to PROF's ROE of -0.70%. Regarding short-term risk, ISRG is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check PROF's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
ISRG vs FOCL Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, FOCL has a market cap of 203.7M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while FOCL trades at $5.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas FOCL's P/E ratio is -6.99. In terms of profitability, ISRG's ROE is +0.17%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, ISRG is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check FOCL's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
ISRG vs ANIK Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ANIK has a market cap of 202.9M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ANIK trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ANIK's P/E ratio is 31.12. In terms of profitability, ISRG's ROE is +0.17%, compared to ANIK's ROE of -0.08%. Regarding short-term risk, ISRG is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ANIK's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
ISRG vs BSGM Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas BSGM's P/E ratio is -5.81. In terms of profitability, ISRG's ROE is +0.17%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, ISRG is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
ISRG vs QTRX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, QTRX has a market cap of 182.1M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while QTRX trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas QTRX's P/E ratio is -2.42. In terms of profitability, ISRG's ROE is +0.17%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, ISRG is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
ISRG vs INGN Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, INGN has a market cap of 180.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while INGN trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas INGN's P/E ratio is -7.32. In terms of profitability, ISRG's ROE is +0.17%, compared to INGN's ROE of -0.13%. Regarding short-term risk, ISRG is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check INGN's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
ISRG vs MDGS Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas MDGS's P/E ratio is -0.27. In terms of profitability, ISRG's ROE is +0.17%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, ISRG is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check MDGS's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
ISRG vs TLSI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, TLSI has a market cap of 162.6M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while TLSI trades at $4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas TLSI's P/E ratio is -2.55. In terms of profitability, ISRG's ROE is +0.17%, compared to TLSI's ROE of +1.63%. Regarding short-term risk, ISRG is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check TLSI's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
ISRG vs QIPT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas QIPT's P/E ratio is -15.87. In terms of profitability, ISRG's ROE is +0.17%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, ISRG is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check QIPT's competition here
CVRx, Inc. (NASDAQ: CVRX)
ISRG vs CVRX Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, CVRX has a market cap of 130.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while CVRX trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas CVRX's P/E ratio is -2.43. In terms of profitability, ISRG's ROE is +0.17%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, ISRG is less volatile compared to CVRX. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check CVRX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
ISRG vs RCEL Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, RCEL has a market cap of 126.7M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while RCEL trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas RCEL's P/E ratio is -3.25. In terms of profitability, ISRG's ROE is +0.17%, compared to RCEL's ROE of +3.05%. Regarding short-term risk, ISRG is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check RCEL's competition here
iCAD, Inc. (NASDAQ: ICAD)
ISRG vs ICAD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ICAD's P/E ratio is -20.37. In terms of profitability, ISRG's ROE is +0.17%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, ISRG is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
ISRG vs OWLT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, OWLT has a market cap of 101.1M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while OWLT trades at $5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas OWLT's P/E ratio is -39.93. In terms of profitability, ISRG's ROE is +0.17%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, ISRG is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check OWLT's competition here
Solana Company (NASDAQ: HSDT)
ISRG vs HSDT Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, HSDT has a market cap of 99.8M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while HSDT trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas HSDT's P/E ratio is -0.02. In terms of profitability, ISRG's ROE is +0.17%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, ISRG is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
ISRG vs HJLI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas HJLI's P/E ratio is N/A. In terms of profitability, ISRG's ROE is +0.17%, compared to HJLI's ROE of -0.66%. Regarding short-term risk, ISRG is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check HJLI's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
ISRG vs LUCD Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, LUCD has a market cap of 97.2M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while LUCD trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas LUCD's P/E ratio is -2.57. In terms of profitability, ISRG's ROE is +0.17%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, ISRG is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check LUCD's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
ISRG vs ASXC Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas ASXC's P/E ratio is -1.12. In terms of profitability, ISRG's ROE is +0.17%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, ISRG is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check ASXC's competition here
Rapid Micro Biosystems, Inc. (NASDAQ: RPID)
ISRG vs RPID Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, RPID has a market cap of 93.8M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while RPID trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas RPID's P/E ratio is -1.85. In terms of profitability, ISRG's ROE is +0.17%, compared to RPID's ROE of -1.32%. Regarding short-term risk, ISRG is more volatile compared to RPID. This indicates higher risk in terms of short-term price fluctuations for ISRG.Check RPID's competition here
QT Imaging Holdings, Inc. (NASDAQ: QTI)
ISRG vs QTI Comparison July 2026
Intuitive Surgical, Inc. (NASDAQ: ISRG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISRG stands at 142.5B. In comparison, QTI has a market cap of 89M. Regarding current trading prices, ISRG is priced at $345.42 on the NASDAQ, while QTI trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISRG currently has a P/E ratio of 41.82, whereas QTI's P/E ratio is -4.82. In terms of profitability, ISRG's ROE is +0.17%, compared to QTI's ROE of -63.31%. Regarding short-term risk, ISRG is less volatile compared to QTI. This indicates lower risk in terms of short-term price fluctuations for ISRG.Check QTI's competition here